Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjan C Lankester

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
Pediatric Clinics of North America|February 5, 2008
Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?Terry J Fry, Arjan C Lankester
Hematology/Oncology Clinics of North America|February 2, 2010
Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?Terry J Fry, Arjan C Lankester
Oncoimmunology|June 22, 2012
Immunotherapy: Is it different for sarcomas?Anne-Marie Cleton-Jansen, Emilie P Buddingh, Arjan C Lankester
Pediatric Clinics of North America|March 24, 2010
Immunotherapy in the context of hematopoietic stem cell transplantation: the emerging role of natural killer cells and mesenchymal stromal cellsArjan C Lankester, Lynne M Ball, Peter Lang, et al.
Frontiers in Immunology|July 23, 2016
Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell PopulationsJanine E Melsen, Gertjan Lugthart, Arjan C Lankester, et al.
Current Opinion in Allergy and Clinical Immunology|October 17, 2023
Advances in gene therapy for inborn errors of immunityLisa M Ott de Bruin, Arjan C Lankester, Frank J T Staal
Frontiers in Immunology|April 30, 2019
B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in ChildrenNicolaas G van der Maas, Dagmar Berghuis, Mirjam van der Burg, et al.
Pediatric Blood & Cancer|August 28, 2023
Long-term parental distress after pediatric hematopoietic stem cell transplantation for nonmalignant diseasesJoëll E Bense, Anne M Stiggelbout, Arjan C Lankester, et al.
Pediatric Blood & Cancer|January 12, 2017
The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patientsMatthijs D Kruizinga, Dorine Bresters, Frans J Smiers, et al.
Frontiers in Immunology|June 20, 2018
Immunoglobulin G Fragment Crystallizable Glycosylation After Hematopoietic Stem Cell Transplantation Is Dissimilar to Donor ProfilesNoortje de Haan, Maarten J D van Tol, Gertjan J Driessen, et al.
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Pediatric Clinics of North America|February 5, 2008
Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?Terry J Fry, Arjan C Lankester
Hematology/Oncology Clinics of North America|February 2, 2010
Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?Terry J Fry, Arjan C Lankester
Oncoimmunology|June 22, 2012
Immunotherapy: Is it different for sarcomas?Anne-Marie Cleton-Jansen, Emilie P Buddingh, Arjan C Lankester
Pediatric Clinics of North America|March 24, 2010
Immunotherapy in the context of hematopoietic stem cell transplantation: the emerging role of natural killer cells and mesenchymal stromal cellsArjan C Lankester, Lynne M Ball, Peter Lang, et al.
Frontiers in Immunology|July 23, 2016
Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell PopulationsJanine E Melsen, Gertjan Lugthart, Arjan C Lankester, et al.
Current Opinion in Allergy and Clinical Immunology|October 17, 2023
Advances in gene therapy for inborn errors of immunityLisa M Ott de Bruin, Arjan C Lankester, Frank J T Staal
Frontiers in Immunology|April 30, 2019
B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in ChildrenNicolaas G van der Maas, Dagmar Berghuis, Mirjam van der Burg, et al.
Pediatric Blood & Cancer|August 28, 2023
Long-term parental distress after pediatric hematopoietic stem cell transplantation for nonmalignant diseasesJoëll E Bense, Anne M Stiggelbout, Arjan C Lankester, et al.
Pediatric Blood & Cancer|January 12, 2017
The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patientsMatthijs D Kruizinga, Dorine Bresters, Frans J Smiers, et al.
Frontiers in Immunology|June 20, 2018
Immunoglobulin G Fragment Crystallizable Glycosylation After Hematopoietic Stem Cell Transplantation Is Dissimilar to Donor ProfilesNoortje de Haan, Maarten J D van Tol, Gertjan J Driessen, et al.
Pageof 16